Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study

• Main Authors: Eric Yuk Fai Wan, PhD (Author), Celine Sze Ling Chui, PhD (Author), Yuan Wang, MStat (Author), Vanessa Wai Sei Ng, BPharm (Author), Vincent Ka Chun Yan, BPharm (Author), Francisco Tsz Tsun Lai, PhD (Author), Xue Li, PhD (Author), Carlos King Ho Wong, PhD (Author), Esther Wai Yin Chan, PhD (Author), Christina Sze Man Wong, MD (Author), Kathy Sze Man Leung, PhD (Author), Michael Yuxuan Ni, MD (Author), Sophie Alessandra Valkenburg, PhD (Author), Joseph Sriyal Malik Peiris, DPhil (Author), Joseph Tsz Kei Wu, PhD (Author), Benjamin John Cowling, PhD (Author), Darren M Ashcroft, PhD (Author), Ivan Fan Ngai Hung, MD (Author), Gabriel Matthew Leung, MD (Author), Ian Chi Kei Wong, PhD (Author)
• Format: Book
• Published: Elsevier, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Stimulation of immunity by vaccination may elicit adverse events. There is currently inconclusive evidence on the relationship between herpes zoster related hospitalization and COVID-19 vaccination. This study aimed to evaluate the effect of inactivated virus (CoronaVac, Sinovac...